L’Oréal is to buy Skinbetter Science, a physician-dispensed US skin care brand.
The label, which claims to combine efficacious ingredients with luxurious sensorial textures, was founded in 2016 by pharmaceutical industry professionals Jonah Shacknai, Justin Smith and Seth Rodner.
Skinbetter Science focuses on anti-ageing, moisturising, cleansing, exfoliating, skin peeling and sun protection.
Its products are mainly available through a network of dermatology, plastic surgery and medical aesthetics practices throughout the US.
The Arizona-headquartered business recorded nearly US$95m in sales for the year ended 31 August 2022.
Its leadership team will continue to run the business following the acquisition, integrated under the leadership of Christina Fair, President of the Active Cosmetics Division within L’Oréal USA.
“Skinbetter Science is a perfect complement to the Active Cosmetics Division’s brand portfolio,” said Myriam Cohen-Welgryn, Worldwide President of L’Oréal’s Active Cosmetics Division.
“It will contribute greatly to the L’Oréal Active Cosmetics Division’s longstanding mission to pioneer health and beauty with advanced science-based skin care innovations. I am confident this high growth US brand has great international potential.”
David Greenberg, Chief Executive Officer, L’Oréal USA and President, North America Zone, added: “We are thrilled to welcome the Skinbetter Science team to L’Oréal.
“I am confident the brand will strengthen our North America dermatological beauty business, an area that we believe has dynamic growth potential.
“Together with Christina Fair and our Active Cosmetics Division, we see an opportunity to draw on the strength of the fantastic team behind the brand and reinforce the relationships of trust that they have built with their healthcare professional partners to take this part of our business to the next level.”
“The entire Skinbetter Science team is excited to be joining the L’Oréal family,” added Jonah Shacknai, Founder & Executive Chairman of Skinbetter Science.
“L’Oréal is the leading beauty company in the world, and its extraordinary leadership, resources and international reach will allow us to maximise opportunities for medical aesthetics practices, patients and our Skinbetter colleagues.
“We are very proud of all we have accomplished as an independent brand and look forward to collaboration with such an innovative and socially responsible global organisation.
“We genuinely believe there to be superb mission and values alignment between our companies.”
The deal is expected to close in early Q4 2022, subject to standard regulatory approvals.